89 related articles for article (PubMed ID: 25912275)
21. Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
Belani CP; Brodowicz T; Ciuleanu TE; Krzakowski M; Yang SH; Franke F; Cucevic B; Madhavan J; Santoro A; Ramlau R; Liepa AM; Visseren-Grul C; Peterson P; John WJ; Zielinski CC
Lancet Oncol; 2012 Mar; 13(3):292-9. PubMed ID: 22336221
[TBL] [Abstract][Full Text] [Related]
22. Measuring the symptom experience of Chinese cancer patients: a validation of the Chinese version of the memorial symptom assessment scale.
Cheng KK; Wong EM; Ling WM; Chan CW; Thompson DR
J Pain Symptom Manage; 2009 Jan; 37(1):44-57. PubMed ID: 18538976
[TBL] [Abstract][Full Text] [Related]
23. Distress and patient-centered communication among veterans with incidental (not screen-detected) pulmonary nodules. A cohort study.
Slatore CG; Golden SE; Ganzini L; Wiener RS; Au DH
Ann Am Thorac Soc; 2015 Feb; 12(2):184-92. PubMed ID: 25521482
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
25. The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.
Chang VT; Xia Q; Kasimis B
J Support Oncol; 2005; 3(5):377-82. PubMed ID: 16218262
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors of survival in patients with advanced cancer admitted to home care.
Mercadante S; Valle A; Porzio G; Aielli F; Adile C; Casuccio A;
J Pain Symptom Manage; 2013 Jan; 45(1):56-62. PubMed ID: 23017625
[TBL] [Abstract][Full Text] [Related]
27. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS).
Chang VT; Hwang SS; Kasimis B; Thaler HT
Cancer Invest; 2004; 22(4):526-36. PubMed ID: 15565810
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system.
Laird BJ; Kaasa S; McMillan DC; Fallon MT; Hjermstad MJ; Fayers P; Klepstad P
Clin Cancer Res; 2013 Oct; 19(19):5456-64. PubMed ID: 23938289
[TBL] [Abstract][Full Text] [Related]
29. New insights in symptom assessment: the Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS).
Lam WW; Law CC; Fu YT; Wong KH; Chang VT; Fielding R
J Pain Symptom Manage; 2008 Dec; 36(6):584-95. PubMed ID: 18434076
[TBL] [Abstract][Full Text] [Related]
30. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
Park SJ; Lee CS; Chung SS
Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
[TBL] [Abstract][Full Text] [Related]
31. The clinical utility of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in Turkish lung cancer patients.
Yüceege M; Sanisoğlu B; Fırat H; Ersoy Y; Sevgi E; Kurt EB
Clin Respir J; 2015 Apr; 9(2):221-7. PubMed ID: 25849299
[TBL] [Abstract][Full Text] [Related]
32. Prognostic effect of symptomatic extracranial lesions on survival of recursive partitioning analysis Class III brain metastatic patients treated with stereotactic radiotherapy.
Chen XJ; Xiao JP; Li XP; Jiang XS; Zhang Y
J Cancer Res Ther; 2016; 12(1):215-20. PubMed ID: 27072240
[TBL] [Abstract][Full Text] [Related]
33. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
[TBL] [Abstract][Full Text] [Related]
34. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
Quinten C; Martinelli F; Coens C; Sprangers MA; Ringash J; Gotay C; Bjordal K; Greimel E; Reeve BB; Maringwa J; Ediebah DE; Zikos E; King MT; Osoba D; Taphoorn MJ; Flechtner H; Schmucker-Von Koch J; Weis J; Bottomley A;
Cancer; 2014 Jan; 120(2):302-11. PubMed ID: 24127333
[TBL] [Abstract][Full Text] [Related]
35. Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients.
Webber K; Davies AN
J Pain Symptom Manage; 2011 Nov; 42(5):761-7. PubMed ID: 21530154
[TBL] [Abstract][Full Text] [Related]
36. First-year trends in self-reported general health predict survival in patients with head and neck cancer.
Jameson MJ; Karnell LH; Christensen AJ; Funk GF
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):958-64. PubMed ID: 18794441
[TBL] [Abstract][Full Text] [Related]
37. Survival analysis of 272 patients with pancreatic cancer undergoing combined treatment.
Cao N; Zhao A; Zhao G; Wang X; Han B; Lin R; Zhao Y; Yang J
Integr Cancer Ther; 2015 Mar; 14(2):133-9. PubMed ID: 25567328
[TBL] [Abstract][Full Text] [Related]
38. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.
Loprinzi CL; Laurie JA; Wieand HS; Krook JE; Novotny PJ; Kugler JW; Bartel J; Law M; Bateman M; Klatt NE
J Clin Oncol; 1994 Mar; 12(3):601-7. PubMed ID: 8120560
[TBL] [Abstract][Full Text] [Related]
39. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
[TBL] [Abstract][Full Text] [Related]
40. Spanish Version of the Patient Dignity Inventory: Translation and Validation in Patients With Advanced Cancer.
Rullán M; Carvajal A; Núñez-Córdoba JM; Martínez M; Carrasco JM; García I; Arantzamendi M; Belar A; Centeno C
J Pain Symptom Manage; 2015 Dec; 50(6):874-81.e1. PubMed ID: 26342725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
